Betadine Trial -Does use of Betadine solution to wound prior to closure of skin at caesarean section affect wound healing and or infection after caesarean section

Does use of Betadine solution to wound prior to closure of skin at caesarean section affect wound healing and or infection after caesarean section

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12611000379910

Acronym

Nil

Enrollment

3304

Registered

2011-04-12

Start date

2010-04-01

Completion date

2014-04-30

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Infection after c/section is a concern for women and health workers. Prophylactic antibiotics are used to prevent infection but some will still develop the complication. betadine is routinely used for skin preparation prior to c/section. It is believed that its use again immediately prior to skin closure may further reduce the infection rate. This is an open randomsied controlled trial. Hospital infection control dept routinely make contact with all c/section women. This source will be used to gather information on women who develop any problem with ht ewound. They routinely provide consent to be contacted for this purpose and therefore no additional consent will be required .

Interventions

prior to closure of skin at caesarean section women will be randomised to betadine or no betadine soak of the wound. 20 mls of betadine solution is poured onto the incision site prior to skin closure and skin closed as normal practice within 30 seconds.

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Prevention

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

0 to No maximum

Healthy volunteers

Inclusion criteria

all women having caesarean section

Exclusion criteria

nil

Outcome results